On June 21, June 21, the website of CDE showed a list of the 20 drug registration applications that are expected to be included in the priority review process. Involves varieties is injecting paclitaxel (albumin), respectively is the meaning by shiyao group pharmaceutical co., LTD and jiangsu hengrui pharmaceutical co., LTD., the proposed generic drug applications. It is worth noting that both companies have completed the BE study of the breed.
Article 20 the approval of the list of public registers for the application of the pharmaceutical registration of the priority assessment procedure shall be included
